Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rFXIII in Cardiac Surgery
NCT00914589Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2009
- Primary completion
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 2 trial of catridecacog in acquired factor XIII deficiency, sponsored by Novo Nordisk. Started Jul 2009; status: completed.
02
Drugs
catridecacog
03
Conditions
acquired factor XIII deficiency
Beyond the preview
Go deeper on NCT00914589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914589.